Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 72162-2516

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Divalproex Fig1)

A cumulative distribution curve chart comparing the percent reduction in CPS rate between Divalproex Sodium Delayed-Release Tablets and placebo. The y-axis shows percentage improvement from -100% worsening to 100% improvement, while the x-axis represents percentage of patients from 0 to 100%.*

FDA Label Image

Figure 2 (Divalproex Fig2)

A line graph comparing the percentage of patients versus the percentage reduction in CPS rate for high dose and low dose Divalproex Sodium delayed-release tablets. The y-axis represents improvement or worsening in CPS rate, while the x-axis shows the percentage of patients. The graph includes solid and dashed lines representing high dose and low dose groups respectively.*

FDA Label Image

Figure-3 (Divalproex Fig3)

A bar chart comparing the effect of Placebo versus Divalproex Sodium Extended-Release Tablets. The y-axis measures a variable with values up to 1.2. The Divalproex Sodium bar reaches 1.2 and is marked with an asterisk indicating statistical significance (p=0.006), while the Placebo bar is at 0.6. The chart visually represents the increased effect of the Divalproex Sodium extended-release tablets compared to placebo.*

FDA Label Image

Structure (Divalproex Str)

Chemical structure of divalproex sodium showing its molecular composition with sodium ions and carbon chains. The diagram depicts the repeating unit structure typical for this compound.*

FDA Label Image

Label (Lbl721622516)

Label for Divalproex Sodium Extended-Release Tablets USP 500 mg by Bryant Ranch Prepack. The label states each film-coated tablet contains divalproex sodium equivalent to 500 mg valproic acid. It includes storage instructions, a QR code for prescribing info, and notes it contains 100 tablets. Manufactured by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.